Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Shanchol in Infants with EPI Vaccines
NCT00548054Phase 2Unknown
- Sponsor
- International Vaccine Institute
- Start
- Dec 2015
- Primary completion
- Aug 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cholera vaccine (inactivated, oral) in cholera (6 arms), sponsored by International Vaccine Institute. Primary endpoints: Proportion of subjects with diarrhea and Proportion of subjects exhibiting 4-fold or greater rises in titers of serum vibriocidal antibodies. Status: unknown.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT00548054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548054.